Patents by Inventor Teresa Born

Teresa Born has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070172456
    Abstract: The invention is directed to novel, purified and isolated IL-1 zeta and Xrec2 polypeptides and fragments thereof, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and uses thereof.
    Type: Application
    Filed: March 13, 2007
    Publication date: July 26, 2007
    Applicant: Immunex Corporation
    Inventors: John Sims, Dirk Smith, Teresa Born
  • Publication number: 20070135625
    Abstract: A novel polypeptide that functions as an IL-18 receptor is disclosed. The receptor is multimeric and includes at least one AcPL polypeptide, or fragment thereof, and at least one IL-1Rrp1 polypeptide, or fraction thereof. The receptor binds IL-18 and finds use in inhibiting biological activities mediated by IL-18.
    Type: Application
    Filed: January 29, 2007
    Publication date: June 14, 2007
    Applicant: Immunex Corporation
    Inventors: John Sims, Teresa Born
  • Publication number: 20050281824
    Abstract: The invention relates to the discovery that IMXP-888, a protein with homology to the FGF receptor family, is a proinflammatory cytokine. The invention encompasses therapeutic compositions of IMXP-888 polypeptides and antagonists, methods of use thereof, and screening methods.
    Type: Application
    Filed: July 21, 2005
    Publication date: December 22, 2005
    Applicant: Immunex Corporation
    Inventors: Stewart Chipman, Kenneth Schooley, Teresa Born, Robert DuBose
  • Publication number: 20050013797
    Abstract: The invention is directed to novel, purified and isolated IL-1 zeta and Xrec2 polypeptides and fragments thereof, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and uses thereof.
    Type: Application
    Filed: July 9, 2004
    Publication date: January 20, 2005
    Inventors: John Sims, Dirk Smith, Teresa Born
  • Publication number: 20050013798
    Abstract: The invention is directed to novel, purified and isolated IL-1 zeta and Xrec2 polypeptides and fragments thereof, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and uses thereof.
    Type: Application
    Filed: July 9, 2004
    Publication date: January 20, 2005
    Inventors: John Sims, Dirk Smith, Teresa Born
  • Publication number: 20050009075
    Abstract: The invention is directed to novel, purified and isolated IL-1 zeta and Xrec2 polypeptides and fragments thereof, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and uses thereof.
    Type: Application
    Filed: July 9, 2004
    Publication date: January 13, 2005
    Inventors: John Sims, Dirk Smith, Teresa Born
  • Publication number: 20050009138
    Abstract: The invention is directed to novel, purified and isolated IL-1 zeta and Xrec2 polypeptides and fragments thereof, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and uses thereof.
    Type: Application
    Filed: July 9, 2004
    Publication date: January 13, 2005
    Inventors: John Sims, Dirk Smith, Teresa Born